Pfizer

Pfizer Capital Intensity

The Capital Intensity Ratio of Pfizer (PFIZER.NS) as of Nov 12, 2026 is 195.34 %. In the previous year, Capital Intensity Ratio was 215.27 % — a change of -9.26% (lower).

Capital Intensity

195.34 %

YoY

-9.26%

Last updated:

Capital Intensity Ratio of Pfizer is 2026 195.34 % . Capital Intensity Ratio of Pfizer was 2025 215.27 % . It decreases by -9.26% lower compared to the previous year.

The Pfizer Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2019
189.29 INR
Jan 1, 2020
204.75 INR
Jan 1, 2021
145.78 INR
Jan 1, 2022
149.39 INR
Jan 1, 2023
164.99 INR
Jan 1, 2024
192.82 INR
Jan 1, 2025
215.27 INR
Jan 1, 2026
195.34 INR
The Pfizer Capital Intensity history
YEARCapital IntensityYoY
195.34 %-9.26%
215.27 %+11.65%
192.82 %+16.86%
164.99 %+10.45%
149.39 %+2.48%
145.78 %-28.80%
204.75 %+8.17%
189.29 %+0.98%
187.45 %+12.69%
166.34 %+14.88%
144.79 %+2.74%
140.93 %+182.53%
49.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pfizer stock

Capital Intensity Ratio of Pfizer is 195.34 % in 2026.

Capital Intensity Ratio of Pfizer changed from 215.27 % to 195.34 %, representing a -9.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Pfizer since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Pfizer with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Pfizer

All Key Metrics — Pfizer